Escolar Documentos
Profissional Documentos
Cultura Documentos
www.elsevier.com/locate/jpa
www.sciencedirect.com
SHORT COMMUNICATION
a
Dipartimento di Chimica, Universita degli Studi di Pavia, Via Taramelli 12/14/16, 27100 Pavia Italy
b
Dipartimento di Scienze Teoriche ed Applicate (DSTA), Universita dellInsubria, Via Dunant, 7, 21100 Varese Italy
KEYWORDS Abstract A robust voltammetric method has been developed and validated for the determination
Sodium ferric gluconate
of Fe(II) and Fe(III) in pharmaceutical iron polysaccharidic complexes. Undesirable low molecular
complex; weight iron complexes, at concentration about 3% in the pharmaceutical formulation, can be easily
Iron sucrose complex; determined with good accuracy and precision. This methodology can be proposed as a viable,
Iron polysaccharides; environmentally sustainable substitute for the conventional Normal Pulse Polarographic method in
Voltammetry US Pharmacopeia, with better analytical gures of merit, and reduced Hg consumption. A deeper
insight in Fe(II) and Fe(III) composition can be gained by the combined use of a new
potentiometric technique after chemical decomposition of the complex.
& 2012 Xian Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
2095-1779 & 2012 Xian Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.jpha.2012.05.003
An analytical method for Fe(II) and Fe(III) determination in iron complexes by DPV 451
consumptions. A redox titration method for the selective determi- 3. Results and discussion
nation of Fe(II) is also reported.
3.1. Determination of Fe(II) by NPP
Table 1 Voltammetric results obtained in the determina- Table 2 Comparison of R1/R2 values obtained by DPV
tion of Fe(III) and Fe(II) by calibration curves. and NPP methods (n 3).
Complex Fe(III) peak Fe(II) peak (total iron Complex DPV NPP
quantication)
R1/R2 RSD (%) R1/R2 RSD (%)
ISC I (mA) 0.017(2) mg/ I (mA) 0.035(2) mg/
LFe(III)0.1(1) LFe0.2(3) ISC 2.03 3.8 1.86 12.4
R2 0.998 (10 data R2 0.997 (10 data SFGC 2.09 3.6 1.77 11.5
points) points) Expected value 2.0 2.0
Acknowledgment [6] E.M. Coe, L.H. Bowen, J.A. Speer, et al., The recharacterization
of a polysaccharide iron complex (Niferex), J. Inorg. Biochem. 58
This work was nancially supported by FAR, Fondo Ateneo (1995) 269278.
per la Ricerca Universita di Pavia, Italy. We thank Prof. Nick [7] D.S. Kudasheva, J. Lai, A. Ulman, et al., Structure of carbohy-
drate-bound polynuclear iron oxyhydroxide nanoparticles in
Serpone for useful discussions.
parenteral formulations, J. Inorg. Biochem. 98 (2004) 17571769.
[8] United States Pharmacopeia, 31th Edition, US Pharmacopeial
References Convention, 2008, 2, pp. 24492450.
[9] Y.-Y. Zhang, J.-H. Liu, Optimization of process conditions for
[1] L. Gyurcsik, B. Nagy, Metal complexes of carbohydrates and preparing an iron-polysaccharide complex by response surface
their derivatives: coordination equilibrium and structure, Coord. methodology, Chem. Biochem. Eng. Q. 25 (1) (2011) 7581.
Chem. Rev. 203 (2000) 81149. [10] L. Nagy, T. Gajda, J. Kurti, et al., Spectroscopic studies of
[2] L. Nagy, A.J. Szorcsik, Equilibrium and structural studies on iron(III) complexes of D-saccharose and D-glucose in the solid
metal complexes of carbohydrates and their derivatives, Inorg. state and in solution, J. Radioanal. Nucl. Chem. 209 (1) (1996)
Biochem. 89 (2002) 112. 225234.
[3] F. Jones, H. Colfen, M. Antonietti, Iron oxyhydroxide colloids [11] F. Scholz, Electroanalytical Methods: Guide to Experiments and
stabilized with polysaccharides, Colloid Polym. Sci. 278 (2001) Applications, Springer Verlag, Berlin, 2002, pp. 105.
491501. [12] R.L. Pecsok, J. Sandera, The gluconate complexes. II. The ferric-
[4] L.L. Brunton, J.S. Lazo, K.L. Parker, in: Goodman & Gilmans gluconate system, J. Am. Chem. Soc. 77 (6) (1995) 14891494.
The Pharmacological Basis of Therapeutics, 11th Edition, [13] (a) ICH Q2A, Validation of Analytical Procedures: Denitions
McGraw-Hill, New York, 2006, pp. 14421450 (Italian edition). and Terminology, Geneva, 1995, in 2005 incorporated in Q2(R1)
[5] S. Sweetman, in: Martindale: The Complete Drug Reference, 35th (b) ICH Q2B, Validation of Analytical Procedures: Methodology,
Edition, Pharmaceutical Press, New York, 2007, pp. 13661370. adopted in 1995, Geneva Q2B, in 2005 incorporated in Q2(R1).